| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/16/2008 | CN101219133A Levorotation carnitine pellet and method for preparing the same |
| 07/16/2008 | CN101219122A Hydrochloric acid glitazone dispersion piece and its preparation method |
| 07/16/2008 | CN101219121A Pitavastatin calcium tablet and method for preparing the same |
| 07/16/2008 | CN101218978A Protein powder added cucumber seed powder |
| 07/16/2008 | CN101218958A Process for manufacturing saccharified fibre feedstuff |
| 07/16/2008 | CN101218954A Chinese cabbage ice cream |
| 07/16/2008 | CN100402530C Pyrimidotriazines as phosphatase inhibitors |
| 07/16/2008 | CN100402521C 4-imidazolin-2-one compounds |
| 07/16/2008 | CN100402510C Oxazole derivatives and their use as insulin sensitizers |
| 07/16/2008 | CN100402505C Preparation of allantoin and allantoin extract from cistanche salsa and their use thereof |
| 07/16/2008 | CN100402497C Fluorinated vitamin D3 analogs |
| 07/16/2008 | CN100402072C Health-care food capsule capable of detoxification and fat lowering and its preparation method |
| 07/16/2008 | CN100402055C Health-care food with blood-sugar decreasing function, and its preparing method |
| 07/16/2008 | CN100402052C Blood fat-reducing medicine and its preparation method |
| 07/16/2008 | CN100402045C Starfish and seaweed compound product and its preparing method |
| 07/16/2008 | CN100402042C Composition and method for augmenting kidney function |
| 07/16/2008 | CN100402034C Composite amino acid and vitamine capsule preparation and its preparing method |
| 07/16/2008 | CN100402026C Use of substituted cyanopyrrolidines and combination preparations containing them for treating hyperlipidemia and associated diseases |
| 07/16/2008 | CN100401912C Slowly digestable starch product |
| 07/15/2008 | US7399878 Pharmaceutical compounds |
| 07/15/2008 | US7399840 Proteosome influenza vaccine |
| 07/15/2008 | US7399829 Variants of RANKL protein |
| 07/15/2008 | US7399821 Alkylated poly(allylamine) polymers and methods of use |
| 07/15/2008 | US7399780 pyridin-2-yl-1H-indole or pyrimidin-4-yl-1H-indole derivatives; enzyme inhibitor of glycogen synthase kinase-3; treating dementia, Alzheimer's Disease, Parkinson's Disease, amyotrophic lateral sclerosis, corticobasal degeneration, Down syndrome, Huntington's Disease |
| 07/15/2008 | US7399779 3,6-disubstituted azabicyclo [3.1.0] hexane derivatives useful as muscarinic receptor antagonists |
| 07/15/2008 | US7399774 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| 07/15/2008 | US7399745 polypeptides, fragments and/or variants, used for treatment of metabolic disorders, such as diabetes and obesity; hypoglycemic agents |
| 07/15/2008 | US7399485 Rapidly Disintegrable solid preparation |
| 07/15/2008 | US7399464 Polypeptides of the IFNα-7 gene |
| 07/15/2008 | CA2395530C Calcium formate for use as a phosphorus binder and a dietary supplement |
| 07/15/2008 | CA2392096C Polymorphic form of atorvastatin calcium |
| 07/15/2008 | CA2362515C Utilization of material containing docosapentaenoic acid |
| 07/15/2008 | CA2282184C Stable, pulverulent lycopene formulations, comprising lycopene having a degree of crystallinity of greater than 20% |
| 07/15/2008 | CA2271857C Method for treating symptoms of diabetes |
| 07/15/2008 | CA2207103C Methods to identify hemochromatosis |
| 07/15/2008 | CA2156083C Variants of bile salt-stimulated lipase, dna molecules encoding them, and transgenic non-human mammals |
| 07/10/2008 | WO2008083238A2 Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders |
| 07/10/2008 | WO2008083200A2 Spiroheterocyclic glycosides and methods of use |
| 07/10/2008 | WO2008083124A1 N-substituted-heterocycloalkyloxybenzamide compounds and methods of use |
| 07/10/2008 | WO2008082250A1 Improved process for the preparation of non-crystalline atorvastatin calcium |
| 07/10/2008 | WO2008082017A1 Cyclic sulfonium salt, method for production of cyclic sulfonium salt, and glycosidase inhibitor |
| 07/10/2008 | WO2008081834A1 Food containing glycogen and use thereof |
| 07/10/2008 | WO2008081208A1 Piperidine gpcr agonists |
| 07/10/2008 | WO2008081207A1 Piperidine gpcr agonists |
| 07/10/2008 | WO2008081206A1 Piperidine gpcr agonists |
| 07/10/2008 | WO2008081205A1 Piperidine gpcr agonists |
| 07/10/2008 | WO2008081204A1 Piperidine gpcr agonists |
| 07/10/2008 | WO2008081009A2 Amorphous rimonabant and rimonabant solvates and processes for their preparation |
| 07/10/2008 | WO2008080461A1 5-phenyl-6-pyridin-4-yl-1,3-dihydro-2h-imidazo[4,5-b]pyridin-2-one derivatives useful as a2b adenosine receptor antagonists |
| 07/10/2008 | WO2008080287A1 L-carnitine calcium fumarate, preparation method and application for the same |
| 07/10/2008 | WO2008064107A3 7,8-dihydro-1,6-naphthyridin-5(6h)-ones and related bicyclic compounds as inhibitors of dipeptidyl peptidase iv and methods |
| 07/10/2008 | WO2008064107A2 7,8-dihydro-1,6-naphthyridin-5(6h)-ones and related bicyclic compounds as inhibitors of dipeptidyl peptidase iv and methods |
| 07/10/2008 | WO2008015558A3 Beta-3 receptor ligands and their use in therapy |
| 07/10/2008 | WO2007121256A3 Rapid acting and long acting insulin combination formulations |
| 07/10/2008 | WO2007115821A3 Organic compounds |
| 07/10/2008 | WO2007096739A3 Intestinal alpha-glucosidase inhibitors and a process for the isolation and use thereof |
| 07/10/2008 | WO2002072778A3 Method for identifying inhibitors of g protein coupled receptor signaling |
| 07/10/2008 | US20080167378 For the 14273 peroxisome proliferator activated receptor; antidiabetic agents, hyperlipidemia, obesity or anorexia; receptor binding assay; drug screening kits |
| 07/10/2008 | US20080167364 Ramipril-amine salts |
| 07/10/2008 | US20080167362 Time-release tablets or capsules also containing an opoid or analgesic; cyclooxygenase-2 inhibitors |
| 07/10/2008 | US20080167359 guanidines such as (1H-benzoimidazol-2-yl)(2,6-dichlorophenyl)methylamine, used as proton pump inhibitors for prevention or treatment of respiratory system, sleep, urogenital or nervous ststem disorders; as antihypotensive, neuroleptic, antidepressants, anxiolytic, antiischemic or antilipemic agents |
| 07/10/2008 | US20080167356 metabolic syndrome, diabetes, cholestatic liver disease, fibrosis; improved glucose tolerance and decreased insulin resistance; 6-[4-({[3-(2,6-dichlorophenyl)-5-(1-methylethyl)-4-isoxazolyl]methyl}oxy)phenyl]-1-naphthalenecarboxylic acid |
| 07/10/2008 | US20080167355 Benzooxazol-2-one derivatives as lipase and phospholipase inhibitors |
| 07/10/2008 | US20080167354 Treatment and/or prevention of disorders of fatty acid metabolism and glucose utilization and insulin resistance; 2-(hetero)aryloxazol-4-ylalkylcycloalkyl group, (2R/2S)-3-[(1R,3S)-3-(5-methyl-2-m-tolyloxazol-4-ylmethoxymethyl)-cyclohexyloxy ]-2-(4-trifluoromethylbenzyloxy)propionic acid |
| 07/10/2008 | US20080167345 Amide substituted indazoles as poly(ADP-ribose)polymerase(PARP) inhibitors |
| 07/10/2008 | US20080167339 Hormone sensitive diseases; atherosclerosis; cardiovascular disorders; congestive heart failure; antidiabetic agents; metaboolism disorders; reducing triglycweride concentration |
| 07/10/2008 | US20080167321 Administering pyridine, pyrimidine or pyridazine derivatives, e.g., N-Hexyl-2-[4-(5-hexylamino-2-trifluoromethylbenzoyl)piperazin-1-yl]isonicotinamide and 5-[4-(5-Fluoro-2-trifluoromethylbenzoyl)piperazin-1-yl]-N-pentylnicotinamide, to treat Type II diabetes, obesity, fatty liver, and metabolic syndrome |
| 07/10/2008 | US20080167313 Antidiabetic agents; dyslipidemia; hhypoglycemic agents; atherosclerosis ; obesity; antiinflammatory agents; metabolism disorders |
| 07/10/2008 | US20080167310 Syndrome X, antidiabetic agents; hypoglycemic agents;antilipemic agents; artherosclerosis; cardiovascular disorders |
| 07/10/2008 | US20080167306 Novel Heteroaryl Derivative |
| 07/10/2008 | US20080167257 Therapy of acroparaesthsia, allergic (psoric) conditions, allergic reactions, alopecia, amnesia, anaphrodisia, angina, arthritis, asthenopia, biliary sycosis, burns, cancerous conditions, such as colon cancer, malignant melanoma and malignant nasal polyps, carpal tunnel syndrome, colds, conjunctivitis |
| 07/10/2008 | US20080167240 Albumin Fusion Proteins |
| 07/10/2008 | US20080167239 Albumin Fusion Proteins |
| 07/10/2008 | US20080167227 biodrug laminin protein as angiogenesis inhibitors, antitumor agents; Inducing apoptosis in tissues; binding antibodies |
| 07/10/2008 | US20080167226 solution contains GLP-1(7-37) or an analogue wherein an amino acid residue of the parent peptide has a lipophilic substituent attached optionally via a spacer; pH is 7-10; stability, long shelf life; biodrug for stimulating insulin secretion, lowing blood glucose |
| 07/10/2008 | US20080167224 polypeptide with at least one amino acid replacement at position at 132, 134, 170, or 181; agonist of MET receptor; induce DNA synthesis, protect from liver damage from acetaminophen; gene therapy; promote cell growth angiogenesis, treatment of cardiovascular, hepatic, musculoskeletal, neuronal diseases |
| 07/10/2008 | US20080166768 Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptide and heterodimer thereof |
| 07/10/2008 | US20080166438 Chromones As Therapeutic Agents |
| 07/10/2008 | US20080166433 Methods and Composition For Dietary Supplements |
| 07/10/2008 | US20080166432 Biotherapeutics for Mitigation of Health Disorders from Terminalia Arjuna |
| 07/10/2008 | US20080166408 Oral Dosage Form Comprising Rosiglitazone |
| 07/10/2008 | DE202008005904U1 Kalt geknackte Cashewnuss zur Anwendung in der Therapie Cold cracked cashew nut for use in the therapy |
| 07/10/2008 | CA2674455A1 Piperidine gpcr agonists |
| 07/10/2008 | CA2674360A1 Piperidine gpcr agonists |
| 07/10/2008 | CA2674355A1 Piperidine gpcr agonists |
| 07/10/2008 | CA2674348A1 Piperidine gpcr agonists |
| 07/10/2008 | CA2674237A1 N-substituted-heterocycloalkyloxybenzamide compounds and methods of use |
| 07/10/2008 | CA2674093A1 Piperidine gpcr agonists |
| 07/09/2008 | EP1942187A1 Cytokine protein family |
| 07/09/2008 | EP1942115A1 Agglutinable glp-1 analogue and sustained-release pharmaceutical composition |
| 07/09/2008 | EP1941907A1 Inhibitor of transplanted islet dysfunction in islet transplantation |
| 07/09/2008 | EP1941900A1 Novel exendin agonist compounds |
| 07/09/2008 | EP1941899A1 Agent for promoting glucagon-like peptide 1 secretion, food or drink for promoting glucagon-like peptide 1 secretion, agent for inhibiting postprandial increase in blood sugar level and food or drink for inhibiting postprandial increase in blood sugar level |
| 07/09/2008 | EP1941896A1 Dipeptide-containing composition for oral administration |
| 07/09/2008 | EP1941040A1 Modulation of glucocorticoid receptor expression |
| 07/09/2008 | EP1941012A2 A process for the removal of sterols and other compounds from glycerol oils |
| 07/09/2008 | EP1940880A2 Treating diabetes using inhibitors of il-1 |
| 07/09/2008 | EP1940842A2 Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators |
| 07/09/2008 | EP1940838A1 Triazolopyridine derivatives as inhibitors of lipases and phospholipases |
| 07/09/2008 | EP1940823A2 Substituted 1-amino-phthalzine derivatives, preparation and therapeutic use thereof |